CytoDyn Inc (QB) (CYDY) Quote

The half truths return riding in on the high tide of Helene.
Begging for the bargains. Come on all, what's the prob now?
Kind of rough waters lately with the storm surge?

$CYDY$ 2024 and beyond! Great job CytoDyn Team.

Clean your glasses!

But the PR lays out as one of the data points Leronlimab's effectiveness vs Madrigal's drug - i.e. a direct comparison / competition between Leronlimab vs. Madrigal's drug. So I don't get the point about not wanting to "risk a fight" with Madrigal - if you don't want that, you don't publish your results in direct competition with their drug.

My point is that Madrigal has the resources to really set us free - $4 Bln market cap and the market leader in a big market. If our drug (in combination) shows statis significantly better efficacy, they'll selfishly want to work with us - as it would further solidify their position (and help us) in a huge market. It's a win for everyone - and maybe a fast one.

I'm happy with the result as i stated. But we've said we can't do NASH alone. And our drug, while better, didn't exactly crush their drug in the head to head - so I'd be very curious how we could do in combination.

No because they already showed their stupid drug isn't any better than what's already available in animals. Maybe they can try to treat bacteria next. Bunch of morons.

Any chance Dr. J pivots the entire company to a veterinary focus to treat mice and monkeys? People love their pets and are willing to spend big $$ on them. No FDA to worry about is another bonus. The TAM must be around $500K a year, at least.

Well, ya see your problem there is that you come onto this board to defend her. When people point out to you that she has directly lied about us, well, you actually use the same tactic she did, which is calling us paid bashers. I know for 100% fact that no one is paying me for my thoughts, however when they don't align with what you all wish them to be, I must be a paid basher. Even when it is so much more logical that someone would be getting paid to promote the stock, not denigrate it. The company has denigrated itself.
And who would care to pay someone to say bad things about this bad stock? It is trading at SIXTEEN CENTS and got there all on its own merit.
BTW, she got herself kicked off the "island" (even though she really isn't). She posted people's personal info on more than one occasion.
You really should leave it to her to defend herself.

"But, as others have mentioned - i wondered why there was no update on the combination of our drug & Madrigal's. I actually thought that was the point of the study - but maybe i misunderstood."

The data analysis is not complete. This was a preliminary heads up, that the raw data looks very strong. Leronlimab should do everything the other drug can do. Therefore, there might be (most likely) no synergistic effect in combination. Additionally, it is very possible that Leronlimab might perform better in a well populated human, stage three trial. But, why risk a fight with a company that has an approved treatment, and why risk raising the hackles of the FDA. This was to let investors know that there are indications that may justify Leronlimab going into a phase three trial for this indication (something that is worth shopping around for a partnership). Madrigal might be interested in it as an option for intermediate to severe Mash. Who knows? We will have to wait until the data is fully processed and analyzed.

because even though it was a good deal, it required coming out of pocket with add'l cash to tender the warrants. i definitely thought about it - but i figure if this ends up working out, i'll make a lot of $ on the warrants anyway, which still have a few years to expiration.

# 1 On Breakout Board 2nd day! A lot of announcements to be made before end of year.


Come get with it shortie pies and brain dead leronsaline analysts. FEED ME AND FEED ME NOW.


$$$CYDY$$$ The tide has shifted. Leronlimab and leronlimab plus.... to rock the medical world with some big name collaborators. Significantly better than approved drug in recent study!

Must read...again and again until it sinks in.

GlobeNewswire
8:30 AM ET Sep-09-2024

VANCOUVER, Washington, Sept. 09, 2024 (GLOBE NEWSWIRE) --

Dear Shareholders,

It continues to be a transformative year for CytoDyn Inc. (CYDY.NaE) (“CytoDyn” or the “Company”). A year in which we have made significant strides as a company, pursuing strategic initiatives to further our clinical development pipeline and charting the path forward in support of our mission. I sincerely thank you for your continued support and remain excited for what lies ahead.

As we enter the final stretch of 2024, let me first acknowledge that there is still a great deal of work ahead of us. The board of directors and the management team of the Company remain focused on advancing our clinical pipeline and opportunities to drive value for shareholders.

We are committed to being transparent with our shareholders and it is my pleasure to provide an update on some key developments described below.

CytoDyn (CYDY.NaE) has accomplished a number of milestones since the FDA lifted the clinical hold on leronlimab in March 2024, including: (i) the submission of two clinical trial protocols to the FDA, (ii) the negotiation of various agreements with vendors and creditors, and (iii) the settlement of litigation with Amarex resulting in an immediate $10 million cash influx into the Company, with an additional $2 million to be received in 2025. These important developments were necessary steps to prepare the way for CytoDyn (CYDY.NaE) to launch pivotal studies to address the potential role of leronlimab in the clinic.

As of today, the Company has a new and improved relationship with the FDA – one that will remain a critical priority for the management team in the coming years. We believe the Company has sufficient cash on hand to commence the contemplated clinical trials and push our development initiatives forward into 2025.

CytoDyn (CYDY.NaE) has made significant progress by initiating a variety of key pre-clinical and clinical leronlimab trials, to be funded by the Company and others.[color=red][/color] I am also pleased to share that we have observed considerable progress related to development of a longer-acting therapeutic with our partner, who utilizes a proprietary artificial intelligence platform to expedite the clinical development process.

As shareholders, you remain the lifeblood of the Company, and we remain committed to acting in your best interests. We are unwavering in our belief that by continuing to take the best next step, one after another, we will continue to hit key milestones in the coming year and, in the process, drive significant potential value for our shareholders.

My dedication to the Company is grounded in my belief that leronlimab has the potential to be a life-changing therapeutic. Our commitment is to drive value for you – the shareholders – and to bring better healthcare to patients in need.

Included below are updates on our top priorities. I am excited about CytoDyn’s prospects moving forward and will provide additional updates as warranted.

Sincerely,

Dr. Jacob Lalezari

“I'm still long shares (and warrants) that i've held onto…”

Blueheel - why do you still have warrants when CYDY had that tender offer recently where you could have exercised them for less than 8 cents a share (which included bonus shares)?

Take off your rose-colored glasses.

I thought it was a solid call and i was impressed with Jay - more so than at any point up to now.

The data on MASH seemed impressive. I took it to mean that the drug worked on it's own with statistical significance, and that it looked better than Madrigal's drug - but slightly missed statistical significance in that regard - so it may be better, but not beyond a shadow of a doubt. It also seemed to reverse fibrosis - which no other drug does right now - at least that was my sense.

Regardless, and even though its' pre-clinical, it's solid data. It also cleared up the 700mg vs. 350mg question that has been very confusing, at least to me. But, as others have mentioned - i wondered why there was no update on the combination of our drug & Madrigal's. I actually thought that was the point of the study - but maybe i misunderstood. Jay has stated that we can't attack MASH alone (too costly) - so isn't partnering the whole point? And if our drug didn't hit statistical significance relative to Madrigal's drug on it's own - how would it be approved as a competing drug?

The other updates (focus on cancer, functional cure for HIV, etc.) were things we generally knew about - so just updates generally.

On balance, I did think it was an excellent call, and Jay did a great job. I'm still long shares (and warrants) that i've held onto, despite concerns about the financial position / ability to prosecute real human trials without raising more capital. I remain of the opinion that we have a good drug, have re-booted from a disastrous path under Nader, and we're in the early innings of version 2.0 of the company. Those who have a long-term / muti-year horizon may make good money here, and i am holding all of my position as a "call option".

It was prob answered--it was just not given to the schlepps that buy shares at market price

They had a privvy call for the qualifieds--Dr J might have revealed more to them than the news??
But the data will be analyzed and what they want us to know (prob just the rosiest parts) will be released. Maybe there will be some writeup that gets published?? That would indicate there is something that other eyes should take a look at

NASH mish MASH is a fools errand except for the superwealthy. The trials--the biopsy stuff-- $$$$$$$$$$$$$$$

The real question is. If they are used together,will this increase their potency. This was not aswered

Your words are to live by.. newsletter has been right on!!

I remember some characters from before. Beating dead horses is not my thing especially when the horse is not in the stable to defend herself.
I will ignore any redundancy.

Simply put leronlimab is no better than the drug already approved. It's over.

No it means that when comparing the two drugs they are not statistically significantly different. Cydy longs are dumb.

What does it appeared mean. Its a word that is not 100 per cent certain. I would hope in a scientific trial,we would have more certain verbage

"I sure wish (well, maybe not) I knew what you were talking about."

All I have ever understood was that his posts are all negative. Therefore, I hardly ever read them (knowing that they are filled with the same, twisted to fit his narrative, crap day in and day out. If a guy reads too much crap like that, it can burn his brain cells out. I'm like you, I get tired of the constant negative posts. Those guys are just hired to influence the new investors with their negativity.

I interpret this to mean that

Best leave interpretation to others

But perhaps wait and see what the ACTUAL results (not preliminary review of results) might bring.

There might not be possible a real apples 2 apples comp at any point--but just in case here is some of the mouse study data from the drug that got approved
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058113/

CYDY would be nuts to spend $$ trying to RCT for nashmash . If the mouse study should find some "partner" and they want to spend millions $$ forbiopsies etc--bring it on. Especially since some of you were not quiet correct in the "partners are lined up as soon as hold is lifted" and the "partners are waiting for conclusion to Samsung debt" nonsense.

MAYBE the mice will bring forth another "silent partner" if can get mice to agree to NDA like the monkeys did . C'mon murine miracle

I sure wish (well, maybe not) I knew what you were talking about.
I used to post here primarily to read Misiu's posts and would occasionally post some charts....backed off from that a few times because some thought charts were nonsense in otc but then did it again (by popular demand of one or two).
I either am not familiar or have chosen to forget the squabbles that went on. Like most IHUB boards there are the longs and the ?
(Not sure what the bashers are...paid bashers or someth8ng else). I really don't care.
I will repeat for the 5th or 10th time, I only know Misiu in my dealings with her. Honest, charitable, generous but passionate in her beliefs. Whatever your problems are with her that is between you and her. Well, guess not because she was kicked off the island.
As for Rockleo, yes I remember him, liked him and perhaps he left for the same reason I did. Got tired of the constant negative commentary here (not just this board).
I had liquidated most of my shares based on TA but O still own shares in another otc that I also do not post in that room because it is as toxic as here.
Glta longs.

Weird, that what is written is not what posts. I posted the second time, to see if the error would duplicate (it did).

Leronlimab showed statistical significance, in the reduction of fibrosis, p=0.01.

"Leronlimab monotherapy (700 mg) demonstrated statistically significant fibrosis reversal compared to an isotype IgG4 control arm (p

Ever seem odd to you that while you went down the "lifetime ban" road which was proven wrong.. Board ban yes--/ IHUB ban NO

That your friend / former poster here the Dr "rockleo"--that also runs the red thread (LLTimes) as "persianleo"--there are no posts there about Cytodyn or LL for 6+ months ?? Remember who posted there and made sure others got banned?? Certainly no "ban" nonsense from Dr Leo for the nodder advocates . No posts there by your buddies for MONTHS

How about the redthread "livimmune"--remember who all posted there and wanted certain posters banned ?? Wonder why they dont post there for months?? Certainly no "ban" nonsense given to any nodder pumper by waxonoff at his livimmune. Yet no posts by your buddies for MONTHS

Sure you want to downplay the witness list in upcoming trial as the reason for these disappearing "acts" by some of the more nefarious players in the khazempourhassan kickback fraud scheme and paid pumper PR firms

Sure you have never heard of those websites--never visited any EVER and just stay busy making sure countries get named or whatever the "raison detate" is for being-- blind in 1 eye and can't see out of the other

G L T U

"Leronlimab monotherapy (700 mg) demonstrated statistically significant fibrosis reversal compared to an isotype IgG4 control arm (p

To answer your question. Yes I have met her. Not her son. Believe what you wish..

Not so lucky. Bought half on the open and other half when it broke above the 200 day sma at .17. Glty.

I know and you think you know (regarding her son). Don't really care what you think.
Like I said several times, she has never lied to me but then I don't have an adversarial relationship with you. Glty. If you are Long you should be happy today, why so snitty?

What a complete crock! misiu has told so many lies about me. When cornered she claims "this is what I was told".....she never ever admits to her mistakes. Janice came over here when misiu started accusing me of working for Janice Shell. then wanted to know why Janice would come to this board.
There is nothing honest about her and I've looked and I see zero evidence of a sick son. And I've seen her family pics. She leaves a personal trail 10 miles long.
Have you met her son? Have you met her?

you have a knack for timing good trades, as i think you got back in around 10 or 11 cents. happy for you, and that has been the way to do it up to this point - simply being a long has not been a profitable approach.

Must have been an omen coming back to the room and defending Misiu yesterday. Today pps broke above the 200 day

CYDY | SharpCharts | StockCharts.com
https://stockcharts.com/sc3/ui/?s=CYDY&a=1766822630&p=D&yr=1&mn=3&dy=10&id=p89372959929

Not much money left. Hopefully something will stick soon

Partnership as a result of this new news in the works? Just wait until the other studies are in print.
Yes, $110 a share one day, not next year, but the company reformed and focused under Dr. J's guidance is on the way. Who is the mysterious Dr. J? Short stumpers should read about him before loose lips catch them wrong as usual. Wrong because they know leronlimab is powerful medicine and leronsaline is made up nonsense. Stick to science and not false postings about the product or about some very qualified doctors and others who support the research.

Every single bit of data gathered since the inception of leronlimab adds to the knowledge base. To say "starting over" is pure horse shit talk by lying incompetent
mommie boys who can't find a real job.

Want to read the fantastic. Go read the last Letter to Shareholders. Then ask yourself, is this starting over? Hello.
Leronlimab continues to march forward. Now we have some momentum growing after the Covid debacle and Nadar/FDA/Amarex problem.
How great savings in research are coming our way with partnerships and institutional collaborations. The future looks strong.

So shortie pies, and flipperfish, get with it. Give me some cheapies. And Hurry!
$CYDY$ 2024 Good job Tanya and Team, but you could do even better with cutting back on the salaries and buying some stock outright. The surgical knife cuts both ways. Hats off to Dr. J.

i do not believe this is a scam. I believe we have a molecule that has value, and i think Jay is a stand-up guy - he would be a great CMO.

My issue here is leadership. We have a chairman of the board who has no business being involved (at any level) here - she's a wealth management compliance officer. We have a CEO who is a good guy, but again, has never dealt with anything of this magnitude (this is a totally different ball of wax than Quest).

Can this team pull it off - a total re-boot of a biotech with limited financial resources? Maybe.

Would our chances (and our investment) be better off with a COB with biotech and deal experience - and with a CEO who has pulled off a turnaround like this before, with specific deal experience in the biotech space?

Those are the questions that need to be asked - at least if investors want this to succeed to the point of recovering some of their hard-earned investment dollars.

Yea, I must have missed that, can you show all of us here where you saw that, I want to see if I should believe you, or a doctor, clinic

Yeah huge news their preclinical trial is a bust! LAUGHING

"Leronlimab monotherapy (700 mg) appears to have better anti-fibrotic activity compared to Resmetirom (p=0.057)."

These guys sure love waving around results that are not statistically significant. What a joke lol. Terrible results for their pre clinical trial. Plus it's pre clinical!!!! Lolllllll

Fabulous news. So after they fired Nadar, they basically restart the company and the trials? $100 in a year or so?

https://www.cytodyn.com/newsroom/press-releases/detail/626/cytodyn-announces-preliminary-findings-in-study-with-smc

Huge news out

I have not been on this board for many months. So I have no clue to what you refer. And since she is not here to defend herself she can not comment on those statements. I defend the person that I have known from first hand experience. And at the risk of redundancy, I will repeat that I have never known her to ORIGINATE a lie and I have personally witnessed her altruistic nature. I had a feeding ministry in the Philippines and she donated to help a child get an operation and donated on other occasions as well.
I can only attest to things to which I have had 1st hand knowledge.

Defending someone that YOU KNOW told lies about 13 D group (I suppose you heard the same lie AND have it recorded also)

Defending someone that YOU KNOW told lies about FDA was to blame for 2 shot vs 4 shot debacle (of course that is calling Dr Lalezare a liar because he specifically stated on video that nodder would not listen to him or Dr Patterson and meet FDA requirements)

Defending someone that YOU KNOW told lies about Dr Pestell and the "acquisition"--when SEC filed docs (linked here MANY times) state there was no prostate test being acquired. And you also know that the liar has said MANYtimes that Pestell should give his shares back--yet NEVER ONCE have you or others asked why/stated that nodder should return his ill gotten shares for the same acquisition

I won't get into the MANY lies about Tony C and Ken VanNess. The lies about Tony C being CEO or nodder purhasing Leronlimab made up nonsense (also proven by SEC docs)

So yes--defending someone that YOU KNOW told lies even AFTER FACTS proved they were 100% lies.That speaks volumes (IMHO)about you and your credibility

And now you come up with some "naming new countries" nonsense . Keep up the ruse

If defending my friend with truth about her honesty strips away my credibility, then by all means strip away. I stand by my comments. Since she is stripped of her rights to defend herself I consider it a privilege to do so for her.
As for the personal info, it is my understanding that a country was named after personal info was posted about Misiu. But I am stating info passed on from Misiu to me. Besides who would believe me, a person with no credibility.

Excellent post.

Posting--doxxing with personal information is not "insensitive remark"

You and dolphin have lost all credibility with your nonsense today. But in your case you didn't ever really have any. But make sure and double down in case someone might still be giving you benefit of doubt--kudos for removing ALL credibilty

Well, I believed in Healthsouth and talked it up a lot. Had no idea the CEO was a freaking ********. And Enron - told my friends about it. Many others. It doesn’t matter how much one talks about a scam that is disguised as a bonafide stock does it? We all are snookered. I mean we on this board know beyond a reasonable doubt that Leronlimab has saved lives who were on their death bed. And yet others, here, say the opposite. Is it a scam?

Your opinion on another’s investment is just an opinion, thank heavens. But suppose you are incorrect? And now, today, your remark leaps the tallest building while she

Can’t even defend herself here.

Probably, in this instance, good because an admin would come along and kick her off for good all because of an insensitive remark.

i say we are years from revenue, and thus years from a much higher share price. unless mice start paying for drugs.

as such, i'll take .50 anytime this year. but you're right, you vote your way and i'll vote mine.

the other thing i will vote against, is every board member. they are a disaster from top to bottom - especially at the top.

Did not what? Didn't post a privacy violation about another poster?

Yes she did.

No. But I wonder if you wrote about them with as much conviction as she did.